RECURSION PHARMACEUTICALS, INC.
A clinical-stage company applying AI and machine learning to drug discovery.
RXRX | US
Overview
Corporate Details
- ISIN(s):
- US75629V1044
- LEI:
- Country:
- United States of America
- Address:
- 41S RIO GRANDE STREET, 84101 SALT LAKE CITY
- Website:
- https://www.recursion.com/
Description
Recursion Pharmaceuticals is a clinical-stage company that applies artificial intelligence and machine learning to drug discovery. Its central platform, the Recursion Operating System (OS), integrates automated wet-lab biology with advanced computational tools to industrialize the process. By generating vast, proprietary biological and chemical datasets from millions of weekly cellular experiments, the company trains its models to decode biology, identify novel drug targets, and design potential medicines. Recursion's pipeline focuses on developing treatments for conditions with high unmet need, such as rare diseases and aggressive cancers. The company's approach aims to significantly accelerate the drug discovery timeline, improve efficiency, and reduce the high failure rates common in traditional pharmaceutical development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all RECURSION PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for RECURSION PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for RECURSION PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||